"Liquid Biopsy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Obtaining material for pathological examination and analysis, from bodily fluids. Material retrieved includes CELL-FREE NUCLEIC ACIDS; CELL-DERIVED MICROPARTICLES; EXOSOMES; CIRCULATING NEOPLASM CELLS; and other circulating cells and CELLULAR STRUCTURES.
| Descriptor ID |
D000073890
|
| MeSH Number(s) |
E01.370.225.500.384.100.396 E01.370.225.998.054.396 E05.200.500.384.100.396 E05.200.998.054.396 E05.242.384.100.396
|
| Concept/Terms |
Liquid Biopsy- Liquid Biopsy
- Biopsies, Liquid
- Biopsy, Liquid
- Liquid Biopsies
|
Below are MeSH descriptors whose meaning is more general than "Liquid Biopsy".
Below are MeSH descriptors whose meaning is more specific than "Liquid Biopsy".
This graph shows the total number of publications written about "Liquid Biopsy" by people in this website by year, and whether "Liquid Biopsy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liquid Biopsy" by people in Profiles.
-
Circulating non-coding RNAs as a tool for liquid biopsy in solid tumors. Epigenomics. 2025 04; 17(5):335-358.
-
The Landscape of ctDNA in Appendiceal Adenocarcinoma. Clin Cancer Res. 2025 Feb 03; 31(3):551-560.
-
Circulating tumor DNA predicts venous thromboembolism in patients with cancers. J Thromb Haemost. 2025 01; 23(1):139-148.
-
An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer. Hepatol Commun. 2024 06 01; 8(6).
-
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers. Clin Cancer Res. 2022 04 01; 28(7):1268-1276.
-
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies. Cancer Cell. 2021 11 08; 39(11):1519-1530.e4.
-
Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2021 07; 233(1):82-89.e1.
-
Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor. Mol Cancer Ther. 2020 12; 19(12):2598-2611.
-
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nat Rev Clin Oncol. 2020 12; 17(12):757-770.
-
ESR1 mutations in breast cancer. Cancer. 2019 11 01; 125(21):3714-3728.